Dean L. Schorno

CIK: 0001509688

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (8.7%)

Position reduction

Option Exercises (M)9 (39.1%)

Derivative conversions

Awards (A)8 (34.8%)

Compensation grants

Other (G, F, J, C, D, …)4 (17.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RIGL

RIGEL PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (23 total)

RIGL
RIGEL PHARMACEUTICALS INC
Sep 2, 2026
Exercise(M)
Direct
1.3K shares at avg. $24.20$31K
RIGL
RIGEL PHARMACEUTICALS INC
Sep 2, 2026
Exercise(M)
Direct
694 shares at avg. $12.70$9K
RIGL
RIGEL PHARMACEUTICALS INC
Sep 2, 2026
Exercise(M)
Direct
620 shares at avg. $18.70$12K
RIGL
RIGEL PHARMACEUTICALS INC
Sep 2, 2026
Exercise(M)
Direct
2K shares at avg. $24.20$48K
RIGL
RIGEL PHARMACEUTICALS INC
Sep 1, 2026
Tax Payment(F)
Direct
928 shares at avg. $47.50$44K
RIGL
RIGEL PHARMACEUTICALS INC
Jun 17, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
7.4K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Jun 1, 2026
Tax Payment(F)
Direct
928 shares at avg. $29.86$28K
RIGL
RIGEL PHARMACEUTICALS INC
Jun 1, 2026
Exercise(M)
Direct
1.2K shares at avg. $18.70$22K
RIGL
RIGEL PHARMACEUTICALS INC
Jun 1, 2026
Exercise(M)
Direct
2.2K shares at avg. $12.70$28K
RIGL
RIGEL PHARMACEUTICALS INC
Feb 17, 2026
Award(A)
Direct
20.6K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Feb 10, 2026
Tax Payment(F)
Direct
3.5K shares at avg. $34.62$123K
RIGL
RIGEL PHARMACEUTICALS INC
Feb 2, 2026
Tax Payment(F)
Direct
5.5K shares at avg. $36.01$198K
RIGL
RIGEL PHARMACEUTICALS INC
Dec 22, 2025
Exercise(M)
Direct
2K shares at avg. $20.00$40K
RIGL
RIGEL PHARMACEUTICALS INC
Dec 22, 2025
Exercise(M)
Direct
2.8K shares at avg. $24.20$69K
RIGL
RIGEL PHARMACEUTICALS INC
Dec 22, 2025
Exercise(M)
Direct
1.7K shares at avg. $18.70$31K
RIGL
RIGEL PHARMACEUTICALS INC
Sep 15, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
7.4K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Mar 17, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
7.9K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Mar 17, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
5.6K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Feb 5, 2025
Sale(S)
Direct
1.7K shares at avg. $21.93$38K
RIGL
RIGEL PHARMACEUTICALS INC
Feb 4, 2025
Sale(S)
Direct
2K shares at avg. $20.92$43K
RIGL
RIGEL PHARMACEUTICALS INC
Jan 29, 2025
Award(A)
Direct
19.7K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Nov 25, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
6.3K shares-
RIGL
RIGEL PHARMACEUTICALS INC
Aug 30, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
10K shares-

		Type	Shares	Price		Ownership
Sep 2, 2026	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	1,286	$24.20	$31,121	Direct
Sep 2, 2026	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	694	$12.70	$8,814	Direct
Sep 2, 2026	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	620	$18.70	$11,594	Direct
Sep 2, 2026	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	2,000	$24.20	$48,400	Direct
Sep 1, 2026	RIGL RIGEL PHARMACEUTICALS INC	Tax Payment(F)	928	$47.50	$44,080	Direct
Jun 17, 2026	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	7,394	-	-	Direct
Jun 1, 2026	RIGL RIGEL PHARMACEUTICALS INC	Tax Payment(F)	928	$29.86	$27,710	Direct
Jun 1, 2026	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	1,200	$18.70	$22,440	Direct
Jun 1, 2026	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	2,181	$12.70	$27,699	Direct
Feb 17, 2026	RIGL RIGEL PHARMACEUTICALS INC	Award(A)	20,636	-	$0	Direct
Feb 10, 2026	RIGL RIGEL PHARMACEUTICALS INC	Tax Payment(F)	3,546	$34.62	$122,763	Direct
Feb 2, 2026	RIGL RIGEL PHARMACEUTICALS INC	Tax Payment(F)	5,488	$36.01	$197,623	Direct
Dec 22, 2025	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	1,987	$20.00	$39,740	Direct
Dec 22, 2025	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	2,846	$24.20	$68,873	Direct
Dec 22, 2025	RIGL RIGEL PHARMACEUTICALS INC	Exercise(M)	1,667	$18.70	$31,173	Direct
Sep 15, 2025	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	7,394	-	-	Direct
Mar 17, 2025	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	7,850	-	-	Direct
Mar 17, 2025	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	5,625	-	-	Direct
Feb 5, 2025	RIGL RIGEL PHARMACEUTICALS INC	Sale(S)	1,734	$21.93	$38,020	Direct
Feb 4, 2025	RIGL RIGEL PHARMACEUTICALS INC	Sale(S)	2,036	$20.92	$42,595	Direct
Jan 29, 2025	RIGL RIGEL PHARMACEUTICALS INC	Award(A)	19,717	-	$0	Direct
Nov 25, 2024	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	6,250	-	-	Direct
Aug 30, 2024	RIGL RIGEL PHARMACEUTICALS INC	Award(A) Employee Stock Option (right to buy)	10,000	-	-	Direct

1-23 of 23 transactions

About Schorno Dean L

Schorno Dean L (SEC CIK 0001509688) files insider reports with the SEC as EVP & Chief Financial Officer of RIGEL PHARMACEUTICALS INC (RIGL).

Signal8 holds 13 ownership filings by Schorno Dean L, all Form 4s, filed between Sep 4, 2024 and Sep 3, 2026. Those filings report 23 transactions, from Aug 30, 2024 to Sep 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Schorno Dean L's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Schorno Dean L

Sep 2, 2026: Option exercises of RIGL shares (4 lines, Form 4, code M).
Sep 1, 2026: Tax withholding of RIGL shares (Form 4, code F).
Jun 17, 2026: Grant or award of RIGL derivative securities (Form 4, code A).
Jun 1, 2026: Tax withholding of RIGL shares (Form 4, code F).
Jun 1, 2026: Option exercises of RIGL shares (2 lines, Form 4, code M).

Other insiders filing for RIGEL PHARMACEUTICALS INC (RIGL)

Santos David A, EVP, Chief Commercial Officer
RODRIGUEZ RAUL R, CEO, President
Furey Raymond J., EVP, GC, CCO & Corp Sec
HANNAH ALISON L., EVP, Chief Medical Officer
Ali-Jackson Kamil, Director
Rojkjaer Lisa, EVP, Chief Medical Officer

How to read Form 4 transaction codes